Target intelligence / Profile preview

RNA, Ro-associated Y3 pseudogene 4 (RNY3P4)

Target: RNY3P4
Molecular classification: Pseudogene, Non-coding RNA

Overview

RNY3 pseudogene 4 (RNY3P4) is a predicted pseudogene of the human RNY3 gene, which encodes a small, non-coding Y-RNA associated with the Ro60 ribonucleoprotein complex and thought to contribute to RNA quality control, mRNA processing, and DNA replication. Pseudogenes like RNY3P4 arise due to duplication events and generally are not transcribed into functional RNA; their biological functions, disease associations, and therapeutic relevance remain undefined. Unlike its functional parent gene, no evidence supports RNY3P4 as a therapeutic target or as a participant in disease processes or drug interactions.

Other names: RNY3 pseudogene 4RNA, Ro-associated Y3 pseudogene 4RNY3P4RNY3 P4Ro-associated Y3 pseudogene 4

Beyond the preview

Go deeper on RNA, Ro-associated Y3 pseudogene 4 (RNY3P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, Ro-associated Y3 pseudogene 4 (RNY3P4).

Explore the full profile